Benzinga | Jan 27, 2022 05:06PM EST

Taro Pharmaceutical Indus Q3 EPS $0.70 Down From $0.86 YoY, Sales $139.00M Miss $142.22M Estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.70 per share. This is a 18.6 percent decrease over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $139.00 million which missed the analyst consensus estimate of $142.22 million by 2.26 percent. This is a 0.82 percent decrease over sales of $140.15 million the same period last year.